{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:01:23Z","timestamp":1784710883081,"version":"3.55.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Priority Academic Program of Development Jiangsu High Education Institution, and the High-end Talent Program for International Collaboration","award":["S20250254"],"award-info":[{"award-number":["S20250254"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"DOI":"10.1186\/s13099-026-00852-2","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T05:04:14Z","timestamp":1784437454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current and emerging therapeutic strategies targeting adherent-invasive Escherichia coli in Crohn\u2019s disease: a review"],"prefix":"10.1186","volume":"18","author":[{"given":"Layla Ahmed","family":"Mohammed Abdelhadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexia","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"issue":"10432","key":"852_CR1","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger M, Torres J, Vermeire S. Crohn\u2019s disease. Lancet. 2024;403(10432):1177\u201391.","journal-title":"Lancet"},{"issue":"5","key":"852_CR2","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/j.1462-5822.2006.00868.x","volume":"9","author":"S Meconi","year":"2007","unstructured":"Meconi S, Vercellone A, Levillain F, Payr\u00e9 B, Al Saati T, Capilla F, et al. Adherent-invasive Escherichia coli isolated from Crohn\u2019s disease patients induce granulomas in vitro. Cell Microbiol. 2007;9(5):1252\u201361.","journal-title":"Cell Microbiol"},{"issue":"1","key":"852_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.gastro.2023.09.019","volume":"166","author":"A Gilliland","year":"2024","unstructured":"Gilliland A, Chan JJ, De Wolfe TJ, Yang H, Vallance BA. Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care. Gastroenterology. 2024;166(1):44\u201358.","journal-title":"Gastroenterology"},{"issue":"6","key":"852_CR4","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0016-5085(98)70019-8","volume":"115","author":"A Darfeuille-Michaud","year":"1998","unstructured":"Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn\u2019s disease. Gastroenterology. 1998;115(6):1405\u201313.","journal-title":"Gastroenterology"},{"issue":"9","key":"852_CR5","doi-asserted-by":"publisher","first-page":"e12714","DOI":"10.1371\/journal.pone.0012714","volume":"5","author":"S Miquel","year":"2010","unstructured":"Miquel S, Peyretaillade E, Claret L, De Vall\u00e9e A, Dossat C, Vacherie B, et al. Complete genome sequence of Crohn\u2019s disease-associated adherent-invasive E. coli strain LF82. PLoS ONE. 2010;5(9):e12714\u2013e.","journal-title":"PLoS ONE"},{"issue":"1","key":"852_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/1471-2164-11-667","volume":"11","author":"JH Nash","year":"2010","unstructured":"Nash JH, Villegas A, Kropinski AM, Aguilar-Valenzuela R, Konczy P, Mascarenhas M, et al. Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics. 2010;11(1):667.","journal-title":"BMC Genomics"},{"key":"852_CR7","doi-asserted-by":"crossref","unstructured":"Clarke DJ, Chaudhuri RR, Martin HM, Campbell BJ, Rhodes JM, Constantinidou C, et al. Complete genome sequence of the Crohn\u2019s disease-associated adherent-invasive Escherichia coli strain HM605. Am Soc Microbiol; 2011.","DOI":"10.1128\/JB.05374-11"},{"issue":"2","key":"852_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/JB.01290-10","volume":"193","author":"DO Krause","year":"2011","unstructured":"Krause DO, Little AC, Dowd SE, Bernstein CN. Complete genome sequence of adherent invasive Escherichia coli UM146 isolated from Ileal Crohn\u2019s disease biopsy tissue. J Bacteriol. 2011;193(2):583.","journal-title":"J Bacteriol"},{"key":"852_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fimmu.2022.748839","volume":"13","author":"M L\u00f3pez-Siles","year":"2022","unstructured":"L\u00f3pez-Siles M, Camprub\u00ed-Font C, G\u00f3mez del Pulgar EM, Sabat Mir M, Busquets D, Sanz Y, et al. Prevalence, abundance, and virulence of adherent-invasive Escherichia coli in ulcerative colitis, colorectal cancer, and coeliac disease. Front Immunol. 2022;13:569.","journal-title":"Front Immunol"},{"issue":"6","key":"852_CR10","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1172\/JCI30504","volume":"117","author":"N Barnich","year":"2007","unstructured":"Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest. 2007;117(6):1566\u201374.","journal-title":"J Clin Invest"},{"issue":"9","key":"852_CR11","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1128\/IAI.67.9.4499-4509.1999","volume":"67","author":"J Boudeau","year":"1999","unstructured":"Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn\u2019s disease. Infect Immun. 1999;67(9):4499\u2013509.","journal-title":"Infect Immun"},{"issue":"9","key":"852_CR12","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1128\/IAI.69.9.5529-5537.2001","volume":"69","author":"AL Glasser","year":"2001","unstructured":"Glasser AL, Boudeau G, Barnich N, Perruchot MH, Colombel JF, Darfeuille-Michaud A. Adherent invasive Escherichia coli strains from patients with Crohn\u2019s disease survive and replicate within macrophages without inducing host cell death. Infect Immun. 2001;69(9):5529\u201337.","journal-title":"Infect Immun"},{"issue":"10","key":"852_CR13","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1002\/jcp.25717","volume":"232","author":"G Mazzarella","year":"2017","unstructured":"Mazzarella G, Perna A, Marano A, Lucariello A, Aufiero VR, Sorrentino A, et al. Pathogenic Role of Associated Adherent-Invasive Escherichia coli in Crohn\u2019s Disease. J Cell Physiol. 2017;232(10):2860\u20138.","journal-title":"J Cell Physiol"},{"issue":"1","key":"852_CR14","doi-asserted-by":"publisher","first-page":"2587402","DOI":"10.1080\/19490976.2025.2587402","volume":"17","author":"E Bruder","year":"2025","unstructured":"Bruder E, Nedjar H, Quenech\u2019Du N, Chevarin C, Vazeille E, Granotier M, et al. Persistence mechanisms of Crohn\u2019s disease-associated adherent invasive Escherichia coli within macrophages. Gut Microbes. 2025;17(1):2587402.","journal-title":"Gut Microbes"},{"issue":"1","key":"852_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41392-024-01866-5","volume":"9","author":"H Niu","year":"2024","unstructured":"Niu H, Gu J, Zhang Y. Bacterial persisters: molecular mechanisms and therapeutic development. Signal Transduct Target therapy. 2024;9(1):174.","journal-title":"Signal Transduct Target therapy"},{"issue":"1","key":"852_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/19490976.2023.2193115","volume":"15","author":"YH Xu","year":"2023","unstructured":"Xu YH, Qian WW, Huang LY, Wen WW, Li Y, Guo FL, et al. Crohn\u2019s disease-associated AIEC inhibiting intestinal epithelial cell-derived exosomal let-7b expression regulates macrophage polarization to exacerbate intestinal fibrosis. Gut Microbes. 2023;15(1):19.","journal-title":"Gut Microbes"},{"issue":"7","key":"852_CR17","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1016\/j.celrep.2020.01.078","volume":"30","author":"MJ Ormsby","year":"2020","unstructured":"Ormsby MJ, Johnson SA, Carpena N, Meikle LM, Goldstone RJ, McIntosh A, et al. Propionic acid promotes the virulent phenotype of Crohn\u2019s disease-associated adherent-invasive Escherichia coli. Cell Rep. 2020;30(7):2297\u2013305. e5.","journal-title":"Cell Rep"},{"issue":"2","key":"852_CR18","doi-asserted-by":"publisher","first-page":"e01369","DOI":"10.1128\/Spectrum.01369-21","volume":"9","author":"F Pace","year":"2021","unstructured":"Pace F, Rudolph SE, Chen Y, Bao B, Kaplan DL, Watnick PI. The short-chain fatty acids propionate and butyrate augment adherent-invasive Escherichia coli virulence but repress inflammation in a human intestinal enteroid model of infection. Microbiol Spectr. 2021;9(2):e01369\u201321.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"852_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/19490976.2020.1839318","volume":"13","author":"A Agus","year":"2021","unstructured":"Agus A, Richard D, Fa\u00efs T, Vazeille E, Chervy M, Bonnin V, et al. Propionate catabolism by CD-associated adherent-invasive E. coli counteracts its anti-inflammatory effect. Gut Microbes. 2021;13(1):18.","journal-title":"Gut Microbes"},{"issue":"4","key":"852_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ajg.2024.07.011","volume":"25","author":"S Sha","year":"2024","unstructured":"Sha S, Gao H, Zeng H, Chen F, Kang J, Jing Y, et al. Adherent-invasive Escherichia coli LF82 disrupts the tight junctions of Caco-2 monolayers. Arab J Gastroenterol. 2024;25(4):383\u20139.","journal-title":"Arab J Gastroenterol"},{"issue":"10","key":"852_CR21","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/ibd.22908","volume":"18","author":"M Drouet","year":"2012","unstructured":"Drouet M, Vignal C, Singer E, Djouina M, Dubreuil L, Cortot A, et al. AIEC colonization and pathogenicity: influence of previous antibiotic treatment and preexisting inflammation. Inflamm Bowel Dis. 2012;18(10):1923\u201331.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"852_CR22","first-page":"840","volume":"11","author":"M Galtier","year":"2017","unstructured":"Galtier M, Sordi LD, Sivignon A, De Vall\u00e9e A, Maura D, Neut C, et al. Bacteriophages targeting adherent invasive Escherichia coli strains as a promising new treatment for Crohn\u2019s disease. J Crohn\u2019s Colitis. 2017;11(7):840\u20137.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"852_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/microorganisms8010017","volume":"8","author":"G Bonfiglio","year":"2019","unstructured":"Bonfiglio G, Neroni B, Radocchia G, Pompilio A, Mura F, Trancassini M, et al. Growth control of adherent-invasive Escherichia coli (AIEC) by the predator bacteria Bdellovibrio bacteriovorus: a new therapeutic approach for Crohn\u2019s disease patients. Microorganisms. 2019;8(1):17.","journal-title":"Microorganisms"},{"issue":"5","key":"852_CR24","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/jgh.15828","volume":"37","author":"W Reinisch","year":"2022","unstructured":"Reinisch W, H\u00e9buterne X, Buisson A, Schreiber S, Desreumaux P, Primas C, et al. Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn\u2019s disease. J Gastroenterol Hepatol. 2022;37(5):832\u201340.","journal-title":"J Gastroenterol Hepatol"},{"key":"852_CR25","doi-asserted-by":"crossref","unstructured":"Rooks MG, Veiga P, Reeves AZ, Lavoie S, Yasuda K, Asano Y et al. QseC inhibition as an antivirulence approach for colitis-associated bacteria. Proceedings of the National Academy of Sciences. 2017;114(1):142-7.","DOI":"10.1073\/pnas.1612836114"},{"issue":"5","key":"852_CR26","doi-asserted-by":"publisher","first-page":"e02184","DOI":"10.1128\/mbio.02184-22","volume":"13","author":"RR Gerner","year":"2022","unstructured":"Gerner RR, Hossain S, Sargun A, Siada K, Norton GJ, Zheng T, et al. Siderophore immunization restricted colonization of adherent-invasive Escherichia coli and ameliorated experimental colitis. mBio. 2022;13(5):e02184\u201322.","journal-title":"mBio"},{"issue":"1","key":"852_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2024.2380064","volume":"16","author":"G Leccese","year":"2024","unstructured":"Leccese G, Chiara M, Dusetti I, Noviello D, Billard E, Bibi A, et al. AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn\u2019s disease is suppressed by rfaP and ybaT deletion. Gut Microbes. 2024;16(1):22.","journal-title":"Gut Microbes"},{"issue":"10","key":"852_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1099\/mic.0.001509","volume":"170","author":"T Miki","year":"2024","unstructured":"Miki T, Ito M, Haneda T, Kim YG. Outer membrane barrier impairment by envC deletion reduces gut colonization of Crohn\u2019s disease pathobiont Escherichia coli. Microbiology-(UK). 2024;170(10):11.","journal-title":"Microbiology-(UK)"},{"key":"852_CR29","doi-asserted-by":"publisher","unstructured":"Marie MB, Oblette Z, Scalabrini M, Loquet D, Kavanaugh DW, Deniaud D et al. Targeting sialic acid catabolism with polyvalent sialidase inhibitors to mitigate bacterial inflammation in the gut. Bioorg Chem. 2026 Jan;168:109283. Epub 2025 Nov 21. PMID: 41317572. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109283","DOI":"10.1016\/j.bioorg.2025.109283"},{"issue":"6","key":"852_CR30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1462-5822.2012.01768.x","volume":"14","author":"P Lapaquette","year":"2012","unstructured":"Lapaquette P, Bringer MA, Darfeuille-Michaud A. Defects in autophagy favour adherent\u2010invasive Escherichia coli persistence within macrophages leading to increased pro\u2010inflammatory response. Cell Microbiol. 2012;14(6):791\u2013807.","journal-title":"Cell Microbiol"},{"issue":"6","key":"852_CR31","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.dld.2014.02.009","volume":"46","author":"L Bertuccini","year":"2014","unstructured":"Bertuccini L, Costanzo M, Iosi F, Tinari A, Terruzzi F, Stronati L, et al. Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn\u2019s disease. Dig Liver Disease. 2014;46(6):496\u2013504.","journal-title":"Dig Liver Disease"},{"issue":"10","key":"852_CR32","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","volume":"11","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy S, Paramsothy R, Rubin DT, Kamm MA, Kaakoush NO, Mitchell HM, et al. Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis. J Crohn\u2019s Colitis. 2017;11(10):1180\u201399.","journal-title":"J Crohn\u2019s Colitis"},{"key":"852_CR33","doi-asserted-by":"publisher","unstructured":"Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn\u2019s disease. Cochrane database Syst reviews. 2018 Apr 1;4(4):CD000542. PMID: 29607496; PMCID: PMC6494406. https:\/\/doi.org\/10.1002\/14651858.CD000542.pub3","DOI":"10.1002\/14651858.CD000542.pub3"},{"issue":"8","key":"852_CR34","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3390\/cells9081824","volume":"9","author":"G Leccese","year":"2020","unstructured":"Leccese G, Bibi A, Mazza S, Facciotti F, Caprioli F, Landini P, et al. Probiotic Lactobacillus and Bifidobacterium strains counteract adherent-invasive Escherichia coli (AIEC) virulence and hamper IL-23\/Th17 axis in ulcerative colitis, but not in crohn\u2019s disease. Cells. 2020;9(8):1824.","journal-title":"Cells"},{"issue":"2","key":"852_CR35","doi-asserted-by":"publisher","first-page":"2281011","DOI":"10.1080\/19490976.2023.2281011","volume":"15","author":"SA Hamed","year":"2023","unstructured":"Hamed SA, Mohan A, Navaneetha Krishnan S, Wang A, Drikic M, Prince NL, et al. Butyrate reduces adherent-invasive E. coli-evoked disruption of epithelial mitochondrial morphology and barrier function: involvement of free fatty acid receptor 3. Gut Microbes. 2023;15(2):2281011.","journal-title":"Gut Microbes"},{"issue":"2","key":"852_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1128\/AAC.00375-07","volume":"52","author":"S Subramanian","year":"2008","unstructured":"Subramanian S, Roberts CL, Hart CA, Martin HM, Edwards SW, Rhodes JM, et al. Replication of colonic Crohn\u2019s disease mucosal Escherichia coli isolates within macrophages and their susceptibility to antibiotics. Antimicrob Agents Chemother. 2008;52(2):427\u201334.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"852_CR37","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3748\/wjg.v22.i3.1078","volume":"22","author":"O Nitzan","year":"2016","unstructured":"Nitzan O, Elias M, Peretz A, Saliba W. Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol. 2016;22(3):1078.","journal-title":"World J Gastroenterol"},{"key":"852_CR38","doi-asserted-by":"crossref","unstructured":"Dogan B, Scherl E, Bosworth B, Yantiss R, Altier C, McDonough PL et al. Multidrug resistance is common in Escherichia coli associated with ileal Crohn\u2019s disease. Inflamm Bowel Dis. 2013 Jan;19(1):141-50.. .","DOI":"10.1002\/ibd.22971"},{"issue":"4","key":"852_CR39","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/ibd\/izy361","volume":"25","author":"AM Oberc","year":"2019","unstructured":"Oberc AM, Fiebig-Comyn AA, Tsai CN, Elhenawy W, Coombes BK. Antibiotics potentiate adherent-invasive E. coli infection and expansion. Inflamm Bowel Dis. 2019;25(4):711\u201321.","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"852_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/antibiotics9050251","volume":"9","author":"M Martinez-Medina","year":"2020","unstructured":"Martinez-Medina M, Strozzi F, Del Ruiz B, Serrano-Morillas N, Ferrer Bustins N, Mart\u00ednez-Mart\u00ednez L. Antimicrobial resistance profiles of adherent invasive Escherichia coli show increased resistance to \u03b2-lactams. Antibiotics. 2020;9(5):251.","journal-title":"Antibiotics"},{"issue":"4","key":"852_CR41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1053\/j.gastro.2005.01.010","volume":"128","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Van Assche G, Vermeire S, D\u2019Haens G, Baert F, Noman M, et al. Ornidazole for prophylaxis of postoperative Crohn\u2019s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128(4):856\u201361.","journal-title":"Gastroenterology"},{"key":"852_CR42","doi-asserted-by":"crossref","unstructured":"Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Interventions for prevention of post-operative recurrence of Crohn\u2019s disease. Cochrane Database of Systematic Reviews. 2009(4).","DOI":"10.1002\/14651858.CD006873.pub2"},{"issue":"6","key":"852_CR43","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3892\/etm.2012.718","volume":"4","author":"S-L Wang","year":"2012","unstructured":"Wang S-L, Wang Z-R, Yang C-Q. Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Experimental therapeutic Med. 2012;4(6):1051\u20136.","journal-title":"Experimental therapeutic Med"},{"issue":"1","key":"852_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ibd.20608","volume":"15","author":"KT Thia","year":"2009","unstructured":"Thia KT, Mahadevan U, Feagan BG, Wong C, Cockeram A, Bitton A, et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn\u2019s disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2009;15(1):17\u201324.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"852_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ajg.2018.27","volume":"113","author":"GR Lichtenstein","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn\u2019s disease in adults. Official J Am Coll Gastroenterology| ACG. 2018;113(4):481\u2013517.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"issue":"4","key":"852_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/ajg.2011.72","volume":"106","author":"KJ Khan","year":"2011","unstructured":"Khan KJ, Ullman TA, Ford AC, Abreu MT, Abadir A, Marshall JK, et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Official J Am Coll Gastroenterology| ACG. 2011;106(4):661\u201373.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"issue":"3","key":"852_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1053\/j.gastro.2011.11.032","volume":"142","author":"C Prantera","year":"2012","unstructured":"Prantera C, Lochs H, Grimaldi M, Danese S, Scribano ML, Gionchetti P, et al. Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn\u2019s disease. Gastroenterology. 2012;142(3):473\u201381. e4.","journal-title":"Gastroenterology"},{"issue":"7","key":"852_CR48","doi-asserted-by":"publisher","first-page":"jjaf093","DOI":"10.1093\/ecco-jcc\/jjaf093","volume":"19","author":"F Carbonnel","year":"2025","unstructured":"Carbonnel F, Barnich N, Lepage P, H\u00e9buterne X, Michiels C, Gilletta C, et al. A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn\u2019s disease: the TEOREM trial. J Crohn\u2019s Colitis. 2025;19(7):jjaf093.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"852_CR49","doi-asserted-by":"publisher","first-page":"19995","DOI":"10.1038\/s41598-025-04901-9","volume":"15","author":"M Coufalova","year":"2025","unstructured":"Coufalova M, Rodrigo MA, Michalkova H, Milosavljevic V, Hrazdilova K, Zurek L, et al. Antibacterial activity of the novel peptide Pac-525 with the RGD motif against intracellular Escherichia coli. Sci Rep. 2025;15(1):19995.","journal-title":"Sci Rep"},{"issue":"2","key":"852_CR50","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00284-016-1166-x","volume":"74","author":"AA Cisek","year":"2017","unstructured":"Cisek AA, D\u0105browska I, Gregorczyk KP, Wy\u017cewski Z. Phage therapy in bacterial infections treatment: one hundred years after the discovery of bacteriophages. Curr Microbiol. 2017;74(2):277\u201383.","journal-title":"Curr Microbiol"},{"issue":"2","key":"852_CR51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","volume":"25","author":"KE Kortright","year":"2019","unstructured":"Kortright KE, Chan BK, Koff JL, Turner PE. Phage therapy: a renewed approach to combat antibiotic-resistant bacteria. Cell Host Microbe. 2019;25(2):219\u201332.","journal-title":"Cell Host Microbe"},{"issue":"7","key":"852_CR52","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1099\/mic.0.27849-0","volume":"151","author":"H Brussow","year":"2005","unstructured":"Brussow H. Phage therapy: the Escherichia coli experience. Microbiology. 2005;151(7):2133\u201340.","journal-title":"Microbiology"},{"issue":"8","key":"852_CR53","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1111\/j.1462-2920.2011.02644.x","volume":"14","author":"D Maura","year":"2012","unstructured":"Maura D, Morello E, Du Merle L, Bomme P, Le Bougu\u00e9nec C, Debarbieux L. Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice. Environ Microbiol. 2012;14(8):1844\u201354.","journal-title":"Environ Microbiol"},{"issue":"2","key":"852_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/1751-7915.12113","volume":"7","author":"G Bourdin","year":"2014","unstructured":"Bourdin G, Navarro A, Sarker SA, Pittet AC, Qadri F, Sultana S, et al. Coverage of diarrhoea-associated E scherichia coli isolates from different origins with two types of phage cocktails. Microb Biotechnol. 2014;7(2):165\u201376.","journal-title":"Microb Biotechnol"},{"key":"852_CR55","doi-asserted-by":"crossref","unstructured":"Titecat M, Rousseaux C, Dubuquoy C, Foligne B, Rahmouni O, Mahieux S et al. Safety and Efficacy of an AIEC-targeted Bacteriophage Cocktail in a Mice Colitis Model. J Crohn\u2019s Colitis. 2022 Nov 1;16(10):1617-1627. .","DOI":"10.1093\/ecco-jcc\/jjac064"},{"key":"852_CR56","doi-asserted-by":"publisher","unstructured":"Jackson K, Galipeau H, Hann A, Constante M, Zangara M, Bording-Jorgensen M et al. Phage intervention improves colitis and response to corticosteroids by attenuating virulence of Crohn\u2019s disease-associated bacteria. bioRxiv. 2025.06.05.658057. https:\/\/doi.org\/10.1101\/2025.06.05.658057","DOI":"10.1101\/2025.06.05.658057"},{"issue":"6","key":"852_CR57","doi-asserted-by":"publisher","first-page":"823","DOI":"10.4103\/0972-124X.124534","volume":"17","author":"K Harini","year":"2013","unstructured":"Harini K, Ajila V, Hegde S. Bdellovibrio bacteriovorus: A future antimicrobial agent? J Indian Soc Periodontology. 2013;17(6):823\u20135.","journal-title":"J Indian Soc Periodontology"},{"issue":"1","key":"852_CR58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.2041-1014.2010.00595.x","volume":"26","author":"M Van Essche","year":"2011","unstructured":"Van Essche M, Quirynen M, Sliepen I, Loozen G, Boon N, Van Eldere J, et al. Killing of anaerobic pathogens by predatory bacteria. Mol Oral Microbiol. 2011;26(1):52\u201361.","journal-title":"Mol Oral Microbiol"},{"issue":"2","key":"852_CR59","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/0022034508329693","volume":"88","author":"M Van Essche","year":"2009","unstructured":"Van Essche M, Quirynen M, Sliepen I, Van Eldere J, Teughels W. Bdellovibrio bacteriovorus attacks Aggregatibacter actinomycetemcomitans. J Dent Res. 2009;88(2):182\u20136.","journal-title":"J Dent Res"},{"issue":"1","key":"852_CR60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40168-021-01135-5","volume":"9","author":"G Chevalier","year":"2021","unstructured":"Chevalier G, Laveissi\u00e8re A, Desachy G, Barnich N, Sivignon A, Maresca M, et al. Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn\u2019s disease. Microbiome. 2021;9(1):16.","journal-title":"Microbiome"},{"issue":"6","key":"852_CR61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/mBio.01298-15","volume":"6","author":"A Sivignon","year":"2015","unstructured":"Sivignon A, Yan XB, Dorta DA, Bonnet R, Bouckaert J, Fleury E, et al. Development of Heptylmannoside-Based Glycoconjugate Antiadhesive Compounds against Adherent-Invasive Escherichia coli Bacteria Associated with Crohn\u2019s Disease. mBio. 2015;6(6):9.","journal-title":"mBio"},{"issue":"10","key":"852_CR62","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/cbic.201600018","volume":"17","author":"D Alvarez Dorta","year":"2016","unstructured":"Alvarez Dorta D, Sivignon A, Chalopin T, Dumych TI, Roos G, Bilyy RO, et al. The antiadhesive strategy in Crohn\u2032 s disease: orally active mannosides to decolonize pathogenic Escherichia coli from the gut. ChemBioChem. 2016;17(10):936\u201352.","journal-title":"ChemBioChem"},{"issue":"13","key":"852_CR63","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1021\/jm400723n","volume":"56","author":"S Brument","year":"2013","unstructured":"Brument S, Sivignon A, Dumych TI, Moreau N, Roos G, Guerardel Y, et al. Thiazolylaminomannosides as potent antiadhesives of type 1 piliated Escherichia coli isolated from Crohn\u2019s disease patients. J Med Chem. 2013;56(13):5395\u2013406.","journal-title":"J Med Chem"},{"issue":"16","key":"852_CR64","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1039\/C6OB00424E","volume":"14","author":"T Chalopin","year":"2016","unstructured":"Chalopin T, Dorta DA, Sivignon A, Caudan M, Dumych T, Bilyy R, et al. Second generation of thiazolylmannosides, FimH antagonists for E. coli-induced Crohn\u2019s disease. Org Biomol Chem. 2016;14(16):3913\u201325.","journal-title":"Org Biomol Chem"},{"issue":"2","key":"852_CR65","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/MIB.0000000000000280","volume":"21","author":"A Sivignon","year":"2015","unstructured":"Sivignon A, de Vall\u00e9e A, Barnich N, Denizot J, Darcha C, Pign\u00e8de G, et al. Saccharomyces cerevisiae CNCM I-3856 Prevents Colitis Induced by AIEC Bacteria in the Transgenic Mouse Model Mimicking Crohn\u2019s Disease. Inflamm Bowel Dis. 2015;21(2):276\u201386.","journal-title":"Inflamm Bowel Dis"},{"key":"852_CR66","doi-asserted-by":"publisher","first-page":"118415","DOI":"10.1016\/j.carbpol.2021.118415","volume":"271","author":"A Sivignon","year":"2021","unstructured":"Sivignon A, Yu S-Y, Ballet N, Vandekerckove P, Barnich N, Guerardel Y. Heteropolysaccharides from S. cerevisiae show anti-adhesive properties against E. coli associated with Crohn\u2019s disease. Carbohydr Polym. 2021;271:118415.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"852_CR67","doi-asserted-by":"publisher","first-page":"7924","DOI":"10.1038\/s41467-025-63276-7","volume":"16","author":"J Wu","year":"2025","unstructured":"Wu J, Liu Y, Liu R, Xiao C, Xuan L, Wu L, et al. Fishing out AIEC with FimH capturing microgels for inflammatory bowel disease treatment. Nat Commun. 2025;16(1):7924.","journal-title":"Nat Commun"},{"issue":"Supplement1","key":"852_CR68","doi-asserted-by":"publisher","first-page":"S479","DOI":"10.1093\/ecco-jcc\/jjz203.696","volume":"14","author":"W Reinisch","year":"2020","unstructured":"Reinisch W, H\u00e9buterne X, Buisson A, Schreiber S, Desreumaux P, Paillarse J, et al. P568 An open-label, multicenter, phase ib, pharmacokinetic (pk) and safety study of a fimh blocker, Sibofimloc (TAK-018\/EB8018), in patients with Crohn\u2019s disease (CD). J Crohn\u2019s Colitis. 2020;14(Supplement1):S479\u201380.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"7","key":"852_CR69","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2174\/0115734064295521240227052730","volume":"20","author":"M Bourhia","year":"2024","unstructured":"Bourhia M, Hosen ME, Faruqe MO, Tasnim F, Taibi M, Elbouzidi A, et al. Unveiling Therapeutic Avenues for Crohn\u2019s Disease Management: Exploring Inhibitors for Adherent-Invasive Escherichia coli Propanediol Dehydratase. Med Chem. 2024;20(7):741\u201351.","journal-title":"Med Chem"},{"issue":"9","key":"852_CR70","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/ncb0910-814","volume":"12","author":"Z Yang","year":"2010","unstructured":"Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol. 2010;12(9):814\u201322.","journal-title":"Nat Cell Biol"},{"issue":"9272","key":"852_CR71","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/S0140-6736(00)05063-7","volume":"357","author":"J Hampe","year":"2001","unstructured":"Hampe J, Cuthbert A, Croucher PJP, Mirza MM, Mascheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn\u2019s disease in German and British populations. Lancet. 2001;357(9272):1925\u20138.","journal-title":"Lancet"},{"issue":"6837","key":"852_CR72","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"J-P Hugot","year":"2001","unstructured":"Hugot J-P, Chamaillard M, Zouali H, Lesage S, C\u00e9zard J-P, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature. 2001;411(6837):599\u2013603.","journal-title":"Nature"},{"issue":"6837","key":"852_CR73","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature. 2001;411(6837):603\u20136.","journal-title":"Nature"},{"issue":"7422","key":"852_CR74","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host\u2013microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119\u201324.","journal-title":"Nature"},{"key":"852_CR75","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nm.2069","volume":"16","author":"R Cooney","year":"2010","unstructured":"Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 2010;16:90\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"852_CR76","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/ecco-jcc\/jjw127","volume":"11","author":"KM Hooper","year":"2017","unstructured":"Hooper KM, Barlow PG, Stevens C, Henderson P. Inflammatory bowel disease drugs: a focus on autophagy. J Crohn\u2019s Colitis. 2017;11(1):118\u201327.","journal-title":"J Crohn\u2019s Colitis"},{"key":"852_CR77","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1007\/s10620-015-3726-5","volume":"60","author":"AL Henderson","year":"2015","unstructured":"Henderson AL, Brand MW, Darling RJ, Maas KJ, Detzel CJ, Hostetter J, et al. Attenuation of colitis by serum-derived bovine immunoglobulin\/protein isolate in a defined microbiota mouse model. Dig Dis Sci. 2015;60:3293\u2013303.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"852_CR78","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41467-022-28478-3","volume":"13","author":"H-Y Chiang","year":"2022","unstructured":"Chiang H-Y, Lu H-H, Sudhakar JN, Chen Y-W, Shih N-S, Weng Y-T, et al. IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence. Nat Commun. 2022;13(1):874.","journal-title":"Nat Commun"},{"issue":"7","key":"852_CR79","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/ecco-jcc\/jjab236","volume":"16","author":"C Douadi","year":"2022","unstructured":"Douadi C, Vazeille E, Chambon C, H\u00e9braud M, Fargeas M, Dodel M, et al. Anti-TNF agents restrict adherent-invasive Escherichia coli replication within macrophages through modulation of chitinase 3-like 1 in patients with Crohn\u2019s disease. J Crohn\u2019s Colitis. 2022;16(7):1140\u201350.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"5","key":"852_CR80","first-page":"854","volume":"44","author":"B Eiseman","year":"1958","unstructured":"Eiseman B, Silen W, Gs B, Aj K. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44(5):854\u20139.","journal-title":"Surgery"},{"issue":"8630","key":"852_CR81","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(89)91183-5","volume":"333","author":"J Bennet","year":"1989","unstructured":"Bennet J, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1989;333(8630):164.","journal-title":"Lancet"},{"issue":"4","key":"852_CR82","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ajg.2013.59","volume":"108","author":"Z Kassam","year":"2013","unstructured":"Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal Microbiota Transplantation forClostridium difficileInfection: Systematic Review and Meta-Analysis. Official J Am Coll Gastroenterology| ACG. 2013;108(4):500\u20138.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"issue":"5","key":"852_CR83","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E Van Nood","year":"2013","unstructured":"Van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407\u201315.","journal-title":"N Engl J Med"},{"key":"852_CR84","doi-asserted-by":"crossref","unstructured":"Frank DN, St. Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the national academy of sciences. 2007;104(34):13780-5.","DOI":"10.1073\/pnas.0706625104"},{"issue":"2","key":"852_CR85","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","volume":"134","author":"RB Sartor","year":"2008","unstructured":"Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134(2):577\u201394.","journal-title":"Gastroenterology"},{"issue":"6","key":"852_CR86","first-page":"374","volume":"12","author":"J Lopez","year":"2016","unstructured":"Lopez J, Grinspan A. Fecal microbiota transplantation for inflammatory bowel disease. Gastroenterol Hepatol. 2016;12(6):374.","journal-title":"Gastroenterol Hepatol"},{"key":"852_CR87","doi-asserted-by":"publisher","first-page":"1439176","DOI":"10.3389\/fimmu.2024.1439176","volume":"15","author":"M Karimi","year":"2024","unstructured":"Karimi M, Shirsalimi N, Hashempour Z, Salehi Omran H, Sedighi E, Beigi F, et al. Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: A comprehensive literature review. Front Immunol. 2024;15:1439176.","journal-title":"Front Immunol"},{"key":"852_CR88","volume-title":"Understanding host-adherent-invasive Escherichia coli interaction in Crohn\u2019s disease: Opening up new therapeutic strategies","author":"A Agus","year":"2014","unstructured":"Agus A, Massier S, Darfeuille-Michaud A, Billard E, Barnich N. Understanding host-adherent-invasive Escherichia coli interaction in Crohn\u2019s disease: Opening up new therapeutic strategies. BioMed Research International: Hindawi Limited; 2014."},{"issue":"10","key":"852_CR89","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1111\/jgh.15598","volume":"36","author":"SR Fehily","year":"2021","unstructured":"Fehily SR, Basnayake C, Wright EK, Kamm MA. Fecal microbiota transplantation therapy in Crohn\u2019s disease: Systematic review. J Gastroenterol Hepatol. 2021;36(10):2672\u201386.","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"852_CR90","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.crohns.2014.08.006","volume":"8","author":"RJ Colman","year":"2014","unstructured":"Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohn\u2019s Colitis. 2014;8(12):1569\u201381.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"852_CR91","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00384-023-04354-4","volume":"38","author":"S Zhou","year":"2023","unstructured":"Zhou S, Cui Y, Zhang Y, Zhao T, Cong J. Fecal microbiota transplantation for induction of remission in Crohn\u2019s disease: a systematic review and meta-analysis. Int J Colorectal Dis. 2023;38(1):62.","journal-title":"Int J Colorectal Dis"},{"issue":"8","key":"852_CR92","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.4014\/jmb.2002.02044","volume":"30","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zou G, Li B, Du X, Sun Z, Sun Y, et al. Fecal microbiota transplantation (FMT) alleviates experimental colitis in mice by gut microbiota regulation. J Microbiol Biotechnol. 2020;30(8):1132.","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"852_CR93","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41598-019-38628-1","volume":"9","author":"J Delmas","year":"2019","unstructured":"Delmas J, Gibold L, Fa\u00efs T, Batista S, Leremboure M, Sinel C, et al. Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts. Sci Rep. 2019;9(1):2175.","journal-title":"Sci Rep"},{"issue":"5","key":"852_CR94","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/nu11050947","volume":"11","author":"N Green","year":"2019","unstructured":"Green N, Miller T, Suskind D, Lee D. A review of dietary therapy for IBD and a vision for the future. Nutrients. 2019;11(5):947.","journal-title":"Nutrients"},{"issue":"1","key":"852_CR95","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41598-020-69472-3","volume":"10","author":"E Gimier","year":"2020","unstructured":"Gimier E, Chervy M, Agus A, Sivignon A, Billard E, Privat M, et al. Methyl-donor supplementation prevents intestinal colonization by Adherent-Invasive E. coli in a mouse model of Crohn\u2019s disease. Sci Rep. 2020;10(1):16.","journal-title":"Sci Rep"},{"issue":"2","key":"852_CR96","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/MIB.0000000000000282","volume":"21","author":"A Assa","year":"2015","unstructured":"Assa A, Vong L, Pinnell LJ, Rautava J, Avitzur N, Johnson-Henry KC, et al. Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury. Inflamm Bowel Dis. 2015;21(2):297\u2013306.","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"852_CR97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1371\/journal.pone.0052132","volume":"7","author":"KP Nickerson","year":"2012","unstructured":"Nickerson KP, McDonald C. Crohn\u2019s Disease-Associated Adherent-Invasive Escherichia coli Adhesion Is Enhanced by Exposure to the Ubiquitous Dietary Polysaccharide Maltodextrin. PLoS ONE. 2012;7(12):13.","journal-title":"PLoS ONE"},{"issue":"R","key":"852_CR98","first-page":"1","volume":"12","author":"S Guandalini","year":"2008","unstructured":"Guandalini S. Historical perspective of celiac disease. Pediatr Adolesc Med. 2008;12(R):1.","journal-title":"Pediatr Adolesc Med"},{"issue":"8","key":"852_CR99","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jand.2015.04.016","volume":"115","author":"S Kakodkar","year":"2015","unstructured":"Kakodkar S, Farooqui AJ, Mikolaitis SL, Mutlu EA. The specific carbohydrate diet for inflammatory bowel disease: a case series. J Acad Nutr Dietetics. 2015;115(8):1226\u201332.","journal-title":"J Acad Nutr Dietetics"},{"issue":"1","key":"852_CR100","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/19490976.2015.1005477","volume":"6","author":"KP Nickerson","year":"2015","unstructured":"Nickerson KP, Chanin R, McDonald C. Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin. Gut Microbes. 2015;6(1):78\u201383.","journal-title":"Gut Microbes"},{"issue":"4","key":"852_CR101","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.nut.2015.08.025","volume":"32","author":"C Obih","year":"2016","unstructured":"Obih C, Wahbeh G, Lee D, Braly K, Giefer M, Shaffer ML, et al. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition. 2016;32(4):418\u201325.","journal-title":"Nutrition"},{"issue":"3","key":"852_CR102","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.gastro.2011.11.040","volume":"142","author":"AN Ananthakrishnan","year":"2012","unstructured":"Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn\u2019s disease. Gastroenterology. 2012;142(3):482\u20139.","journal-title":"Gastroenterology"},{"issue":"3","key":"852_CR103","doi-asserted-by":"publisher","first-page":"E338","DOI":"10.1152\/ajpendo.00134.2021","volume":"321","author":"TC Lau","year":"2021","unstructured":"Lau TC, Fiebig-Comyn AA, Shaler CR, McPhee JB, Coombes BK, Schertzer JD. Low dietary fiber promotes enteric expansion of a Crohn\u2019s disease-associated pathobiont independent of obesity. Am J Physiol-Endocrinol Metab. 2021;321(3):E338\u201350.","journal-title":"Am J Physiol-Endocrinol Metab"},{"issue":"5","key":"852_CR104","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/nutrit\/nuab062","volume":"80","author":"V Peters","year":"2021","unstructured":"Peters V, Dijkstra G, Campmans-Kuijpers MJE. Are all dietary fibers equal for patients with inflammatory bowel disease? A systematic review of randomized controlled trials. Nutr Rev. 2021;80(5):1179\u201393.","journal-title":"Nutr Rev"},{"issue":"11","key":"852_CR105","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.3390\/ijms23115891","volume":"23","author":"C Plissonneau","year":"2022","unstructured":"Plissonneau C, Sivignon A, Chassaing B, Capel F, Martin V, Etienne M, et al. Beneficial effects of linseed supplementation on gut mucosa-associated microbiota in a physically active mouse model of Crohn\u2019s disease. Int J Mol Sci. 2022;23(11):5891.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"852_CR106","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/gutjnl-2012-302504","volume":"62","author":"ME Sanders","year":"2013","unstructured":"Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EMM, Sartor RB, et al. An update on the use and investigation of probiotics in health and disease. Gut. 2013;62(5):787\u201396.","journal-title":"Gut"},{"issue":"2","key":"852_CR107","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.gtc.2004.02.005","volume":"33","author":"JC Chang","year":"2004","unstructured":"Chang JC, Cohen RD. Medical management of severe ulcerative colitis. Gastroenterol Clin. 2004;33(2):235\u201350.","journal-title":"Gastroenterol Clin"},{"issue":"1","key":"852_CR108","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1365-2036.2003.01638.x","volume":"18","author":"J Boudeau","year":"2003","unstructured":"Boudeau J, Glasser AL, Julien S, Colombel JF, Darfeuille-Michaud A. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent\u2013invasive E. coli strains isolated from patients with Crohn\u2019s disease. Aliment Pharmacol Ther. 2003;18(1):45\u201356.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"852_CR109","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/biology10040322","volume":"10","author":"ID Kwoji","year":"2021","unstructured":"Kwoji ID, Aiyegoro OA, Okpeku M, Adeleke MA. Multi-strain probiotics: synergy among isolates enhances biological activities. Biology. 2021;10(4):322.","journal-title":"Biology"},{"issue":"1","key":"852_CR110","first-page":"1","volume":"2","author":"P n den Abbeele","year":"2016","unstructured":"n den Abbeele P, Marzorati M, Derde M, De Weirdt R, Joan V, Possemiers S, et al. Arabinoxylans, inulin and Lactobacillus reuteri 1063 repress the adherent-invasive Escherichia coli from mucus in a mucosa-comprising gut model. npj Biofilms Microbomes. 2016;2(1):1\u20138.","journal-title":"npj Biofilms Microbomes"},{"issue":"10","key":"852_CR111","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1111\/j.1462-2920.2011.02533.x","volume":"13","author":"P Van den Abbeele","year":"2011","unstructured":"Van den Abbeele P, G\u00e9rard P, Rabot S, Bruneau A, El Aidy S, Derrien M, et al. Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ Microbiol. 2011;13(10):2667\u201380.","journal-title":"Environ Microbiol"},{"key":"852_CR112","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12860-025-00545-9","volume":"26","author":"S Alipour","year":"2025","unstructured":"Alipour S, Halimi H, Asri N, Rostami-Nejad M, Pishkar L, Houri H. Anti-Inflammatory effects of Lactobacillus helveticus and Arthrospira platensis on colonic cells inflamed by Crohn\u2019s disease-associated Escherichia coli. BMC Mol Cell Biology. 2025;26:20.","journal-title":"BMC Mol Cell Biology"},{"issue":"7","key":"852_CR113","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1128\/IAI.00218-10","volume":"78","author":"K Gronbach","year":"2010","unstructured":"Gronbach K, Eberle U, M\u00fcller M, \u00d6lschl\u00e4ger TA, Dobrindt U, Leith\u00e4user F, et al. Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host. Infect Immun. 2010;78(7):3036\u201346.","journal-title":"Infect Immun"},{"issue":"2","key":"852_CR114","doi-asserted-by":"publisher","first-page":"s399","DOI":"10.1093\/ajcn\/73.2.399s","volume":"73","author":"A Bezkorovainy","year":"2001","unstructured":"Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr. 2001;73(2):s399\u2013405.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"852_CR115","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EM, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat reviews Gastroenterol Hepatol. 2021;18(9):649\u201367.","journal-title":"Nat reviews Gastroenterol Hepatol"},{"key":"852_CR116","doi-asserted-by":"publisher","first-page":"127550","DOI":"10.1016\/j.micres.2023.127550","volume":"279","author":"H Om","year":"2024","unstructured":"Om H, Chand U, Kushawaha PK. Postbiotics: An alternative and innovative intervention for the therapy of inflammatory bowel disease. Microbiol Res. 2024;279:127550.","journal-title":"Microbiol Res"},{"issue":"22","key":"852_CR117","doi-asserted-by":"publisher","first-page":"6134","DOI":"10.1111\/febs.70289","volume":"292","author":"D Parada-Venegas","year":"2025","unstructured":"Parada-Venegas D, De la Fuente L\u00f3pez M, Dubois\u2010Camacho K, Landskron G, Blokzijl T, Molina H, et al. Butyrate suppresses mucosal inflammation in inflammatory bowel disease primarily through HDAC3 inhibition in monocytes and macrophages. FEBS J. 2025;292(22):6134\u201357.","journal-title":"FEBS J"},{"issue":"18","key":"852_CR118","doi-asserted-by":"publisher","first-page":"11825","DOI":"10.3390\/ijerph191811825","volume":"19","author":"KG Markovi\u0107","year":"2022","unstructured":"Markovi\u0107 KG, Grujovi\u0107 M\u017d, Kora\u0107evi\u0107 MG, Nikodijevi\u0107 DD, Milutinovi\u0107 MG, Semedo-Lemsaddek T, et al. Colicins and microcins produced by Enterobacteriaceae: characterization, mode of action, and putative applications. Int J Environ Res Public Health. 2022;19(18):11825.","journal-title":"Int J Environ Res Public Health"},{"issue":"10","key":"852_CR119","first-page":"2372","volume":"21","author":"CL Brown","year":"2015","unstructured":"Brown CL, Smith K, Wall DM, Walker D. Activity of species-specific antibiotics against Crohn\u2019s disease\u2013associated adherent-invasive Escherichia coli. Inflamm Bowel Dis. 2015;21(10):2372\u201382.","journal-title":"Inflamm Bowel Dis"},{"key":"852_CR120","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mehy.2016.05.002","volume":"93","author":"R Kot\u0142owski","year":"2016","unstructured":"Kot\u0142owski R. Use of Escherichia coli Nissle 1917 producing recombinant colicins for treatment of IBD patients. Med Hypotheses. 2016;93:8\u201310.","journal-title":"Med Hypotheses"},{"key":"852_CR121","doi-asserted-by":"publisher","unstructured":"De Clercq F, Boisseau N, Leclaire C, Denizot J, Holowacz S, Barnich N et al. Development of a combination of probiotics and plant extracts targeting adherent-invasive Escherichia coli associated with Crohn\u2019s disease. Beneficial Microbes.2025 Sep 5;17(3):305-321. PMID: 40987447. https:\/\/doi.org\/10.1163\/18762891-bja00095","DOI":"10.1163\/18762891-bja00095"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-026-00852-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-026-00852-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-026-00852-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:03:28Z","timestamp":1784707408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13099-026-00852-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":121,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["852"],"URL":"https:\/\/doi.org\/10.1186\/s13099-026-00852-2","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"58"}}